These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2505718)

  • 21. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A; Ratanaprakarn R; Koanantakul B; Ngam-Ukos P
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
    Chaignon M; Barrou Z; Ayad M; Guédon J
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR
    Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
    Wang Z; Li Y; Zhou Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):233-6. PubMed ID: 9868122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice].
    Fressinaud P; Berrut G; Gallois H
    Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):51-9. PubMed ID: 8480986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of essential hypertension in general practice: an open-label study of 47,351 French hypertensive patients treated for one year with perindopril.
    Poggi L; Renucci JF; Denolle T
    Can J Cardiol; 1994 Nov; 10 Suppl D():21D-24D. PubMed ID: 7954035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments?].
    Mesure G; Fallet A; Chevalier JF
    Encephale; 1995; 21(5):609-14. PubMed ID: 8529571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibitors and cough.
    Yeşil S; Yeşil M; Bayata S; Postaci N
    Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitors and the allergist.
    O'Hollaren MT; Porter GA
    Ann Allergy; 1990 Jun; 64(6):503-6. PubMed ID: 2189318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perindopril safety and tolerance in at-risk patients.
    Brichard S; Lambert AE
    Drugs; 1990; 39 Suppl 1():64-70. PubMed ID: 2407494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.